BD CTGCTV2
Apr 2025
179d
Bd Integrated Diagnostic Solutions/Becton, has submitted 1 FDA 510(k) premarket notifications since 2025, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Nucleic Acid Detection System For Non-viral Microorganism(s) Causing Sexually Transmitted Infections . Use the specialty filter in the sidebar to narrow results.